{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:51:32Z","timestamp":1768341092761,"version":"3.49.0"},"reference-count":70,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is a complex multifactorial disorder that is characterised by dysfunctional lipid metabolism and cholesterol homeostasis, and a related chronic inflammatory response. NAFLD has become the most common cause of chronic liver disease in many countries, and its prevalence continues to rise in parallel with increasing rates of obesity. Here, we evaluated the putative NAFLD-attenuating effects of a multicomponent medicine consisting of 24 natural ingredients: Hepar compositum (HC-24).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Ldlr-\/-.Leiden mice were fed a high-fat diet (HFD) with a macronutrient composition and cholesterol content comparable to human diets for 24 weeks to induce obesity-associated metabolic dysfunction, including hepatic steatosis and inflammation. HC-24 or vehicle control was administered intraperitoneally 3 times\/week (1.5 ml\/kg) for the last 18 weeks of the study. Histological analyses of liver and adipose tissue were combined with extensive hepatic transcriptomics analysis. Transcriptomics results were further substantiated with ELISA, immunohistochemical and liver lipid analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HFD feeding induced obesity and metabolic dysfunction including adipose tissue inflammation and increased gut permeability. In the liver, HFD-feeding resulted in a disturbance of cholesterol homeostasis and an associated inflammatory response. HC-24 did not affect body weight, metabolic risk factors, adipose tissue inflammation or gut permeability. While HC-24 did not alter total liver steatosis, there was a pronounced reduction in lobular inflammation in HC-24-treated animals, which was associated with modulation of genes and proteins involved in inflammation (e.g., neutrophil chemokine Cxcl1) and cholesterol homeostasis (i.e., predicted effect on \u2018cholesterol\u2019 as an upstream regulator, based on gene expression changes associated with cholesterol handling). These effects were confirmed by CXCL1 ELISA, immunohistochemical staining of neutrophils and biochemical analysis of hepatic free cholesterol content. Intrahepatic free cholesterol levels were found to correlate significantly with the number of inflammatory aggregates in the liver, thereby providing a potential rationale for the observed anti-inflammatory effects of HC-24.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Free cholesterol accumulates in the liver of Ldlr-\/-.Leiden mice under physiologically translational dietary conditions, and this is associated with the development of hepatic inflammation. The multicomponent medicine HC-24 reduces accumulation of free cholesterol and has molecular and cellular anti-inflammatory effects in the liver.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2021.601160","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T09:32:25Z","timestamp":1616059945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine"],"prefix":"10.3389","volume":"12","author":[{"given":"Andrea M.","family":"Mueller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Kleemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline","family":"Gart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim","family":"van Duyvenvoorde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Verschuren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martien","family":"Caspers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswin","family":"Menke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natascha","family":"Kr\u00f6mmelbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanita","family":"Salic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Seilheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine C.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: Trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.11.039","article-title":"Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the united states","volume":"148","author":"Wong","year":"2015","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/cld.709","article-title":"Disease pathways and molecular mechanisms of nonalcoholic steatohepatitis","volume":"11","author":"Wegermann","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: An overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog Lipid Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.12.016","article-title":"Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH","volume":"50","author":"Caballero","year":"2009","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30333","article-title":"Mouse models of nonalcoholic steatohepatitis: Toward optimization of their relevance to human nonalcoholic steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"B12","article-title":"Biological therapy of liver disorders - results of drug monitoring with 801 patients","author":"Borner","year":"1995","journal-title":"Biol Ther"},{"key":"B13","article-title":"Experience of using of antihomotoxic preparations hepar compositum and engystol in complex treatment patients suffering with viral hepatitis","author":"Vovk","year":"2003","journal-title":"Biol Ther (Ukraine)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6153","article-title":"Silybum marianum (milk thistle) and its main constituent, silymarin, as a potential therapeutic plant in metabolic syndrome: A review","volume":"32","author":"Tajmohammadi","year":"2018","journal-title":"Phytother Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3109\/10715762.2015.1116689","article-title":"Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice","volume":"50","author":"Feng","year":"2016","journal-title":"Free Radic Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-017-2022-7","article-title":"Anti-inflammatory evaluation of the methanolic extract of taraxacum officinale in LPS-stimulated human umbilical vein endothelial cells","volume":"17","author":"Jeon","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.fct.2014.01.019","article-title":"TOP 1 and 2, polysaccharides from taraxacum officinale, inhibit NF\u03baB-mediated inflammation and accelerate Nrf2-induced antioxidative potential through the modulation of PI3K-akt signaling pathway in RAW 264.7 cells","volume":"66","author":"Park","year":"2014","journal-title":"Food Chem Toxicol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/ijms11010067","article-title":"Hypolipidemic and antioxidant effects of dandelion (taraxacum officinale) root and leaf on cholesterol-fed rabbits","volume":"11","author":"Choi","year":"2010","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9020131","article-title":"Phenolic fractions from dandelion leaves and petals as modulators of the antioxidant status and lipid profile in an in vivo study","volume":"9","author":"Majewski","year":"2020","journal-title":"Antioxid (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2018.04.002","article-title":"Study of the effect of the herbal composition SR2004 on hemoglobin A1c, fasting blood glucose, and lipids in patients with type 2 diabetes mellitus","volume":"7","author":"Chatterji","year":"2018","journal-title":"Integr Med Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201600715","article-title":"Whole grain oats, more than just a fiber: Role of unique phytochemicals","volume":"61","author":"Sang","year":"2017","journal-title":"Mol Nutr Food Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2009.75","article-title":"Dietary fat intake in the european prospective investigation into cancer and nutrition: Results from the 24-h dietary recalls","author":"Linseisen","year":"2009","journal-title":"Eur J Clin Nutr"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1159\/000355437","article-title":"Intake of fatty acids in general populations worldwide does not meet dietary recommendations to prevent coronary heart disease: A systematic review of data from 40 countries","volume":"63","author":"Harika","year":"2013","journal-title":"Ann Nutr Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/labinvest.2014.11","article-title":"Metabolically induced liver inflammation leads to NASH and differs from LPS- or IL-1beta-induced chronic inflammation","volume":"94","author":"Liang","year":"2014","journal-title":"Lab Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2016.74","article-title":"Intervention with a caspase-1 inhibitor reduces obesity-associated hyperinsulinemia, non-alcoholic steatohepatitis and hepatic fibrosis in LDLR-\/-.leiden mice","volume":"40","author":"Morrison","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184359","article-title":"Combined treatment with L-carnitine and nicotinamide riboside improves hepatic metabolism and attenuates obesity and liver steatosis","volume":"20","author":"Salic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010001","article-title":"Diet-independent correlations between bacteria and dysfunction of gut, adipose tissue, and liver: A comprehensive microbiota analysis in feces and mucosa of the ileum and colon in obese mice with NAFLD","volume":"20","author":"Gart","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1124\/pr.108.00001","article-title":"Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis","volume":"60","author":"Anderson","year":"2008","journal-title":"Pharmacol Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: A review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"B32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jcmgh.2017.10.001","article-title":"Uncovering a predictive molecular signature for the onset of NASH-related fibrosis in a translational NASH mouse model","volume":"5","author":"van Koppen","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1270","article-title":"Obeticholic acid modulates serum metabolites and gene signatures characteristic of human NASH and attenuates inflammation and fibrosis progression in ldlr-\/-.leiden mice","volume":"2","author":"Morrison","year":"2018","journal-title":"Hepatol Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00132","article-title":"Key inflammatory processes in human NASH are reflected in ldlr(-\/-).leiden mice: A translational gene profiling study","volume":"9","author":"Morrison","year":"2018","journal-title":"Front Physiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/nu11081861","article-title":"Sex-specific differences in fat storage, development of non-alcoholic fatty liver disease and brain structure in juvenile HFD-induced obese ldlr-\/-.leiden mice","volume":"11","author":"Jacobs","year":"2019","journal-title":"Nutrients"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.D023788","article-title":"Adiposoft: Automated software for the analysis of white adipose tissue cellularity in histological sections","volume":"53","author":"Galarraga","year":"2012","journal-title":"J Lipid Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e115922","DOI":"10.1371\/journal.pone.0115922","article-title":"Establishment of a general NAFLD scoring system for rodent models and comparison to human liver pathology","volume":"9","author":"Liang","year":"2014","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0180648","DOI":"10.1371\/journal.pone.0180648","article-title":"A casein hydrolysate based formulation attenuates obesity and associated non-alcoholic fatty liver disease and atherosclerosis in LDLr-\/-.leiden mice","volume":"12","author":"Schoemaker","year":"2017","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1042\/bj2470739","article-title":"Cellular free cholesterol in hep G2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity","volume":"247","author":"Havekes","year":"1987","journal-title":"Biochem J"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000067702.22390.20","article-title":"Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0218459","DOI":"10.1371\/journal.pone.0218459","article-title":"Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in ldlr-\/-.leiden mice","volume":"14","author":"Salic","year":"2019","journal-title":"PloS One"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-123","article-title":"Detecting outliers when fitting data with nonlinear regression -\u00a0a new method based on robust nonlinear regression and the false discovery rate","volume":"7","author":"Motulsky","year":"2006","journal-title":"BMC Bioinf"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-7-115","article-title":"Cell-type specific gene expression profiles of leukocytes in human peripheral blood","volume":"7","author":"Palmer","year":"2006","journal-title":"BMC Genomics"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092014","article-title":"A translational mouse model for NASH with advanced fibrosis and atherosclerosis expressing key pathways of human pathology","volume":"9","author":"van den Hoek","year":"2020","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.10.031","article-title":"Preclinical models of non-alcoholic fatty liver disease","volume":"68","author":"Santhekadur","year":"2018","journal-title":"J Hepatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50132","article-title":"Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis","volume":"37","author":"Musso","year":"2003","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.506188","article-title":"Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects","volume":"111","author":"Tannock","year":"2005","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24696","article-title":"Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials","volume":"54","author":"Corey","year":"2011","journal-title":"Hepatology"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29724","article-title":"Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1668926","article-title":"Multi-drug approaches to NASH: What\u2019s in the development pipeline","volume":"29","author":"Johnston","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.044","article-title":"Association of adipose tissue inflammation with histologic severity of nonalcoholic fatty liver disease","volume":"149","author":"du Plessis","year":"2015","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.226","article-title":"Surgical removal of inflamed epididymal white adipose tissue attenuates the development of non-alcoholic steatohepatitis in obesity","volume":"40","author":"Mulder","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2112-9","article-title":"Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"57","author":"Volynets","year":"2012","journal-title":"Dig Dis Sci"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/biom5031563","article-title":"Roles of chemokines and chemokine receptors in obesity-associated insulin resistance and nonalcoholic fatty liver disease","volume":"5","author":"Xu","year":"2015","journal-title":"Biomolecules"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.12.011","article-title":"Mirtoselect, an anthocyanin-rich bilberry extract, attenuates non-alcoholic steatohepatitis and associated fibrosis in ApoE *3Leiden mice","volume":"62","author":"Morrison","year":"2015","journal-title":"J Hepatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e75290","DOI":"10.1371\/journal.pone.0075290","article-title":"Coordinated and interactive expression of genes of lipid metabolism and inflammation in adipose tissue and liver during metabolic overload","volume":"8","author":"Liang","year":"2013","journal-title":"PloS One"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M034876","article-title":"Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis","volume":"54","author":"Ioannou","year":"2013","journal-title":"J Lipid Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.2","article-title":"The role of neutrophils in the development of liver diseases","volume":"11","author":"Xu","year":"2014","journal-title":"Cell Mol Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.15.8837","article-title":"Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma","volume":"271","author":"Wang","year":"1996","journal-title":"J Biol Chem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.189571","article-title":"Membrane cholesterol is a biomechanical regulator of neutrophil adhesion","volume":"29","author":"Oh","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"e13577","DOI":"10.1371\/journal.pone.0013577","article-title":"Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients","volume":"5","author":"Bertola","year":"2010","journal-title":"PloS One"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31031","article-title":"Interleukin-22 ameliorates neutrophil-driven nonalcoholic steatohepatitis through multiple targets","volume":"72","author":"Hwang","year":"2020","journal-title":"Hepatology"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.05.051","article-title":"Comparison of gene expression patterns between mouse models of nonalcoholic fatty liver disease and liver tissues from patients","volume":"151","author":"Teufel","year":"2016","journal-title":"Gastroenterology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(02)00200-8","article-title":"Neutrophil-mediated tissue injury in alcoholic hepatitis","volume":"27","author":"Jaeschke","year":"2002","journal-title":"Alcohol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00568.2005","article-title":"Mechanisms of liver injury. II. mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions","volume":"290","author":"Jaeschke","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s12020-017-1323-4","article-title":"Neutrophil depletion improves diet-induced non-alcoholic fatty liver disease in mice","volume":"57","author":"Ou","year":"2017","journal-title":"Endocrine"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.601160\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T09:32:28Z","timestamp":1616059948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2021.601160\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":70,"alternative-id":["10.3389\/fendo.2021.601160"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2021.601160","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"article-number":"601160"}}